Home Featured Page 165

Featured

Latest

The Psychedelic News Feed: October 20 – 26, 2025

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed

Q3’25 Investor Survey: What are Investors Most Concerned About?

A European Model: Robert Schoevers on the Continent’s Growing Psychedelic Research Agenda

Psychedelic Insights Playground

Psychedelic Bulletin #106 – DMT Study Skips Set and Setting; Cybin...

Kambô: Another Psychedelic Amphibian?

PT326 – Dr. Rick Barnett, Psy.D – Addiction, Recovery, and Competency...

PT325 – Philip Wolf – Cannabis: The Early Days of Legality,...

The Intertwined Prohibitionist Histories of Psychedelics and Kratom

Psychedelic Bulletin #105 – UK Won’t Foot the Bill for Spravato;...

PT324 – Amanda Reiman, Ph.D., MSW – Web3, NFTs, Cryptocurrencies, and...

Psychedelic Research Bulletin: May 2022

PT323 – Dr. Reid Robison & Steve Thayer, Ph.D. – Ketamine-Assisted...

Psychedelic Bulletin #104 – Mydecine CEO Downplays Insider Activity; UC Davis...

1...164165166...300 Page 165 of 300

The Psychedelic News Feed: October 20 – 26, 2025

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores...

Q3’25 Investor Survey: What are Investors Most Concerned About?

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

The Psychedelic News Feed: October 20 – 26, 2025

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores Breakthrough Therapy Designation; California Bill Signed

Q3’25 Investor Survey: What are Investors Most Concerned About?

A European Model: Robert Schoevers on the Continent’s Growing Psychedelic Research Agenda

Psychedelic Insights Playground

Psychedelic Bulletin #106 – DMT Study Skips Set and Setting; Cybin...

Kambô: Another Psychedelic Amphibian?

PT326 – Dr. Rick Barnett, Psy.D – Addiction, Recovery, and Competency...

PT325 – Philip Wolf – Cannabis: The Early Days of Legality,...

The Intertwined Prohibitionist Histories of Psychedelics and Kratom

Psychedelic Bulletin #105 – UK Won’t Foot the Bill for Spravato;...

PT324 – Amanda Reiman, Ph.D., MSW – Web3, NFTs, Cryptocurrencies, and...

Psychedelic Research Bulletin: May 2022

PT323 – Dr. Reid Robison & Steve Thayer, Ph.D. – Ketamine-Assisted...

Psychedelic Bulletin #104 – Mydecine CEO Downplays Insider Activity; UC Davis...

EDITOR PICKS

The Psychedelic News Feed: October 20 – 26, 2025

Pα+ Psychedelic Bulletin #211: AbbVie Officially Enters Psychedelics; atai-Beckley’s 5-MeO-DMT Scores...

Q3’25 Investor Survey: What are Investors Most Concerned About?

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY